These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19033328)

  • 1. Acrylic copolymers as candidates for drug-eluting coating of vascular stents.
    Silvestri D; Cristallini C; Gagliardi M; Barbani N; D'Acunto M; Ciardelli G; Giusti P
    J Biomater Appl; 2009 Nov; 24(4):353-83. PubMed ID: 19033328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents.
    Richard RE; Schwarz M; Ranade S; Chan AK; Matyjaszewski K; Sumerlin B
    Biomacromolecules; 2005; 6(6):3410-8. PubMed ID: 16283773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of adhesion in drug-eluting stent layers.
    Wolf KV; Zong Z; Meng J; Orana A; Rahbar N; Balss KM; Papandreou G; Maryanoff CA; Soboyejo W
    J Biomed Mater Res A; 2008 Oct; 87(1):272-81. PubMed ID: 18306306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, properties, and drug release of poly(alkyl methacrylate-b-isobutylene-b-alkyl methacrylate).
    Cho JC; Cheng G; Feng D; Faust R; Richard R; Schwarz M; Chan K; Boden M
    Biomacromolecules; 2006 Nov; 7(11):2997-3007. PubMed ID: 17096524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of drug coating on drug eluting stents].
    Luo LL; Wang GX; Yin TY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
    Pan CJ; Tang JJ; Shao ZY; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):105-11. PubMed ID: 17540543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents: role of stent design, delivery vehicle, and drug selection.
    Rodgers CD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S10-5. PubMed ID: 12478230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal stent design for drug delivery.
    Rogers CD
    Rev Cardiovasc Med; 2004; 5 Suppl 2():S9-S15. PubMed ID: 15184829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled delivery of paclitaxel from stent coatings using poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene) and its acetylated derivative.
    Sipos L; Som A; Faust R; Richard R; Schwarz M; Ranade S; Boden M; Chan K
    Biomacromolecules; 2005; 6(5):2570-82. PubMed ID: 16153094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces.
    Seabra AB; da Silva R; de Souza GF; de Oliveira MG
    Artif Organs; 2008 Apr; 32(4):262-7. PubMed ID: 18370938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sculptured drug-eluting stent for the on-site delivery of tacrolimus.
    Minghetti P; Cilurzo F; Selmin F; Casiraghi A; Grignani A; Montanari L
    Eur J Pharm Biopharm; 2009 Nov; 73(3):331-6. PubMed ID: 19686848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of drug loading and release kinetics.
    Whelan DM; van Beusekom HM; van der Giessen WJ
    Semin Interv Cardiol; 1998; 3(3-4):127-31. PubMed ID: 10406681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.